0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cardiac Marker Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-38C8538
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Cardiac Marker Market Insights and Forecast to 2028
BUY CHAPTERS

Global Cardiac Marker Market Research Report 2025

Code: QYRE-Auto-38C8538
Report
August 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cardiac Marker Market

The global market for Cardiac Marker was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Cardiac Marker is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cardiac Marker is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Cardiac Marker include HyTest, Abbott, Roche Diagnostics, BG Medicine, Biomerieux, Critical Diagnostics, DiaDexus, Response Biomedical, Siemens Healthcare, Singulex, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cardiac Marker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiac Marker.
The Cardiac Marker market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cardiac Marker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cardiac Marker manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Cardiac Marker Market Report

Report Metric Details
Report Name Cardiac Marker Market
Segment by Type
  • Creatine kinase (CK) MB
  • Troponin (cTnI and cTnT)
  • BNP & NT-proBNP
  • Myogloblin
  • Others (hs-CRP, D-Dimer, etc.)
Segment by Application
  • Myocardial Infarction
  • Congestive Heart Failure
  • Acute Coronary Syndrome
  • Atherosclerosis
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company HyTest, Abbott, Roche Diagnostics, BG Medicine, Biomerieux, Critical Diagnostics, DiaDexus, Response Biomedical, Siemens Healthcare, Singulex, Thermo Scientific, Trinity Biotech, Sunfory, Lee BioSolutions
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Cardiac Marker manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Cardiac Marker in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Cardiac Marker Market report?

Ans: The main players in the Cardiac Marker Market are HyTest, Abbott, Roche Diagnostics, BG Medicine, Biomerieux, Critical Diagnostics, DiaDexus, Response Biomedical, Siemens Healthcare, Singulex, Thermo Scientific, Trinity Biotech, Sunfory, Lee BioSolutions

What are the Application segmentation covered in the Cardiac Marker Market report?

Ans: The Applications covered in the Cardiac Marker Market report are Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, Others

What are the Type segmentation covered in the Cardiac Marker Market report?

Ans: The Types covered in the Cardiac Marker Market report are Creatine kinase (CK) MB, Troponin (cTnI and cTnT), BNP & NT-proBNP, Myogloblin, Others (hs-CRP, D-Dimer, etc.)

1 Cardiac Marker Market Overview
1.1 Product Definition
1.2 Cardiac Marker by Type
1.2.1 Global Cardiac Marker Market Value Comparison by Type (2024 VS 2031)
1.2.2 Creatine kinase (CK) MB
1.2.3 Troponin (cTnI and cTnT)
1.2.4 BNP & NT-proBNP
1.2.5 Myogloblin
1.2.6 Others (hs-CRP, D-Dimer, etc.)
1.3 Cardiac Marker by Application
1.3.1 Global Cardiac Marker Market Value by Application (2024 VS 2031)
1.3.2 Myocardial Infarction
1.3.3 Congestive Heart Failure
1.3.4 Acute Coronary Syndrome
1.3.5 Atherosclerosis
1.3.6 Others
1.4 Global Cardiac Marker Market Size Estimates and Forecasts
1.4.1 Global Cardiac Marker Revenue 2020-2031
1.4.2 Global Cardiac Marker Sales 2020-2031
1.4.3 Global Cardiac Marker Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Cardiac Marker Market Competition by Manufacturers
2.1 Global Cardiac Marker Sales Market Share by Manufacturers (2020-2025)
2.2 Global Cardiac Marker Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Cardiac Marker Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Cardiac Marker, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cardiac Marker, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cardiac Marker, Product Type & Application
2.7 Global Key Manufacturers of Cardiac Marker, Date of Enter into This Industry
2.8 Global Cardiac Marker Market Competitive Situation and Trends
2.8.1 Global Cardiac Marker Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Cardiac Marker Players Market Share by Revenue
2.8.3 Global Cardiac Marker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cardiac Marker Market Scenario by Region
3.1 Global Cardiac Marker Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Cardiac Marker Sales by Region: 2020-2031
3.2.1 Global Cardiac Marker Sales by Region: 2020-2025
3.2.2 Global Cardiac Marker Sales by Region: 2026-2031
3.3 Global Cardiac Marker Revenue by Region: 2020-2031
3.3.1 Global Cardiac Marker Revenue by Region: 2020-2025
3.3.2 Global Cardiac Marker Revenue by Region: 2026-2031
3.4 North America Cardiac Marker Market Facts & Figures by Country
3.4.1 North America Cardiac Marker Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Cardiac Marker Sales by Country (2020-2031)
3.4.3 North America Cardiac Marker Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cardiac Marker Market Facts & Figures by Country
3.5.1 Europe Cardiac Marker Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Cardiac Marker Sales by Country (2020-2031)
3.5.3 Europe Cardiac Marker Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cardiac Marker Market Facts & Figures by Region
3.6.1 Asia Pacific Cardiac Marker Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Cardiac Marker Sales by Region (2020-2031)
3.6.3 Asia Pacific Cardiac Marker Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cardiac Marker Market Facts & Figures by Country
3.7.1 Latin America Cardiac Marker Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Cardiac Marker Sales by Country (2020-2031)
3.7.3 Latin America Cardiac Marker Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cardiac Marker Market Facts & Figures by Country
3.8.1 Middle East and Africa Cardiac Marker Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Cardiac Marker Sales by Country (2020-2031)
3.8.3 Middle East and Africa Cardiac Marker Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Cardiac Marker Sales by Type (2020-2031)
4.1.1 Global Cardiac Marker Sales by Type (2020-2025)
4.1.2 Global Cardiac Marker Sales by Type (2026-2031)
4.1.3 Global Cardiac Marker Sales Market Share by Type (2020-2031)
4.2 Global Cardiac Marker Revenue by Type (2020-2031)
4.2.1 Global Cardiac Marker Revenue by Type (2020-2025)
4.2.2 Global Cardiac Marker Revenue by Type (2026-2031)
4.2.3 Global Cardiac Marker Revenue Market Share by Type (2020-2031)
4.3 Global Cardiac Marker Price by Type (2020-2031)
5 Segment by Application
5.1 Global Cardiac Marker Sales by Application (2020-2031)
5.1.1 Global Cardiac Marker Sales by Application (2020-2025)
5.1.2 Global Cardiac Marker Sales by Application (2026-2031)
5.1.3 Global Cardiac Marker Sales Market Share by Application (2020-2031)
5.2 Global Cardiac Marker Revenue by Application (2020-2031)
5.2.1 Global Cardiac Marker Revenue by Application (2020-2025)
5.2.2 Global Cardiac Marker Revenue by Application (2026-2031)
5.2.3 Global Cardiac Marker Revenue Market Share by Application (2020-2031)
5.3 Global Cardiac Marker Price by Application (2020-2031)
6 Key Companies Profiled
6.1 HyTest
6.1.1 HyTest Company Information
6.1.2 HyTest Description and Business Overview
6.1.3 HyTest Cardiac Marker Sales, Revenue and Gross Margin (2020-2025)
6.1.4 HyTest Cardiac Marker Product Portfolio
6.1.5 HyTest Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Company Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Cardiac Marker Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Abbott Cardiac Marker Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Roche Diagnostics
6.3.1 Roche Diagnostics Company Information
6.3.2 Roche Diagnostics Description and Business Overview
6.3.3 Roche Diagnostics Cardiac Marker Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Roche Diagnostics Cardiac Marker Product Portfolio
6.3.5 Roche Diagnostics Recent Developments/Updates
6.4 BG Medicine
6.4.1 BG Medicine Company Information
6.4.2 BG Medicine Description and Business Overview
6.4.3 BG Medicine Cardiac Marker Sales, Revenue and Gross Margin (2020-2025)
6.4.4 BG Medicine Cardiac Marker Product Portfolio
6.4.5 BG Medicine Recent Developments/Updates
6.5 Biomerieux
6.5.1 Biomerieux Company Information
6.5.2 Biomerieux Description and Business Overview
6.5.3 Biomerieux Cardiac Marker Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Biomerieux Cardiac Marker Product Portfolio
6.5.5 Biomerieux Recent Developments/Updates
6.6 Critical Diagnostics
6.6.1 Critical Diagnostics Company Information
6.6.2 Critical Diagnostics Description and Business Overview
6.6.3 Critical Diagnostics Cardiac Marker Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Critical Diagnostics Cardiac Marker Product Portfolio
6.6.5 Critical Diagnostics Recent Developments/Updates
6.7 DiaDexus
6.7.1 DiaDexus Company Information
6.7.2 DiaDexus Description and Business Overview
6.7.3 DiaDexus Cardiac Marker Sales, Revenue and Gross Margin (2020-2025)
6.7.4 DiaDexus Cardiac Marker Product Portfolio
6.7.5 DiaDexus Recent Developments/Updates
6.8 Response Biomedical
6.8.1 Response Biomedical Company Information
6.8.2 Response Biomedical Description and Business Overview
6.8.3 Response Biomedical Cardiac Marker Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Response Biomedical Cardiac Marker Product Portfolio
6.8.5 Response Biomedical Recent Developments/Updates
6.9 Siemens Healthcare
6.9.1 Siemens Healthcare Company Information
6.9.2 Siemens Healthcare Description and Business Overview
6.9.3 Siemens Healthcare Cardiac Marker Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Siemens Healthcare Cardiac Marker Product Portfolio
6.9.5 Siemens Healthcare Recent Developments/Updates
6.10 Singulex
6.10.1 Singulex Company Information
6.10.2 Singulex Description and Business Overview
6.10.3 Singulex Cardiac Marker Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Singulex Cardiac Marker Product Portfolio
6.10.5 Singulex Recent Developments/Updates
6.11 Thermo Scientific
6.11.1 Thermo Scientific Company Information
6.11.2 Thermo Scientific Description and Business Overview
6.11.3 Thermo Scientific Cardiac Marker Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Thermo Scientific Cardiac Marker Product Portfolio
6.11.5 Thermo Scientific Recent Developments/Updates
6.12 Trinity Biotech
6.12.1 Trinity Biotech Company Information
6.12.2 Trinity Biotech Description and Business Overview
6.12.3 Trinity Biotech Cardiac Marker Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Trinity Biotech Cardiac Marker Product Portfolio
6.12.5 Trinity Biotech Recent Developments/Updates
6.13 Sunfory
6.13.1 Sunfory Company Information
6.13.2 Sunfory Description and Business Overview
6.13.3 Sunfory Cardiac Marker Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Sunfory Cardiac Marker Product Portfolio
6.13.5 Sunfory Recent Developments/Updates
6.14 Lee BioSolutions
6.14.1 Lee BioSolutions Company Information
6.14.2 Lee BioSolutions Description and Business Overview
6.14.3 Lee BioSolutions Cardiac Marker Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Lee BioSolutions Cardiac Marker Product Portfolio
6.14.5 Lee BioSolutions Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cardiac Marker Industry Chain Analysis
7.2 Cardiac Marker Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cardiac Marker Production Mode & Process Analysis
7.4 Cardiac Marker Sales and Marketing
7.4.1 Cardiac Marker Sales Channels
7.4.2 Cardiac Marker Distributors
7.5 Cardiac Marker Customer Analysis
8 Cardiac Marker Market Dynamics
8.1 Cardiac Marker Industry Trends
8.2 Cardiac Marker Market Drivers
8.3 Cardiac Marker Market Challenges
8.4 Cardiac Marker Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Cardiac Marker Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Cardiac Marker Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Cardiac Marker Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Cardiac Marker Sales (K Doses) of Key Manufacturers (2020-2025)
 Table 5. Global Cardiac Marker Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Cardiac Marker Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Cardiac Marker Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Cardiac Marker Average Price (USD/Dose) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Cardiac Marker, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Cardiac Marker, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Cardiac Marker, Product Type & Application
 Table 12. Global Key Manufacturers of Cardiac Marker, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Cardiac Marker by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiac Marker as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Cardiac Marker Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Cardiac Marker Sales by Region (2020-2025) & (K Doses)
 Table 18. Global Cardiac Marker Sales Market Share by Region (2020-2025)
 Table 19. Global Cardiac Marker Sales by Region (2026-2031) & (K Doses)
 Table 20. Global Cardiac Marker Sales Market Share by Region (2026-2031)
 Table 21. Global Cardiac Marker Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Cardiac Marker Revenue Market Share by Region (2020-2025)
 Table 23. Global Cardiac Marker Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Cardiac Marker Revenue Market Share by Region (2026-2031)
 Table 25. North America Cardiac Marker Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Cardiac Marker Sales by Country (2020-2025) & (K Doses)
 Table 27. North America Cardiac Marker Sales by Country (2026-2031) & (K Doses)
 Table 28. North America Cardiac Marker Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Cardiac Marker Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Cardiac Marker Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Cardiac Marker Sales by Country (2020-2025) & (K Doses)
 Table 32. Europe Cardiac Marker Sales by Country (2026-2031) & (K Doses)
 Table 33. Europe Cardiac Marker Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Cardiac Marker Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Cardiac Marker Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Cardiac Marker Sales by Region (2020-2025) & (K Doses)
 Table 37. Asia Pacific Cardiac Marker Sales by Region (2026-2031) & (K Doses)
 Table 38. Asia Pacific Cardiac Marker Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Cardiac Marker Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Cardiac Marker Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Cardiac Marker Sales by Country (2020-2025) & (K Doses)
 Table 42. Latin America Cardiac Marker Sales by Country (2026-2031) & (K Doses)
 Table 43. Latin America Cardiac Marker Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Cardiac Marker Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Cardiac Marker Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Cardiac Marker Sales by Country (2020-2025) & (K Doses)
 Table 47. Middle East and Africa Cardiac Marker Sales by Country (2026-2031) & (K Doses)
 Table 48. Middle East and Africa Cardiac Marker Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Cardiac Marker Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Cardiac Marker Sales (K Doses) by Type (2020-2025)
 Table 51. Global Cardiac Marker Sales (K Doses) by Type (2026-2031)
 Table 52. Global Cardiac Marker Sales Market Share by Type (2020-2025)
 Table 53. Global Cardiac Marker Sales Market Share by Type (2026-2031)
 Table 54. Global Cardiac Marker Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Cardiac Marker Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Cardiac Marker Revenue Market Share by Type (2020-2025)
 Table 57. Global Cardiac Marker Revenue Market Share by Type (2026-2031)
 Table 58. Global Cardiac Marker Price (USD/Dose) by Type (2020-2025)
 Table 59. Global Cardiac Marker Price (USD/Dose) by Type (2026-2031)
 Table 60. Global Cardiac Marker Sales (K Doses) by Application (2020-2025)
 Table 61. Global Cardiac Marker Sales (K Doses) by Application (2026-2031)
 Table 62. Global Cardiac Marker Sales Market Share by Application (2020-2025)
 Table 63. Global Cardiac Marker Sales Market Share by Application (2026-2031)
 Table 64. Global Cardiac Marker Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Cardiac Marker Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Cardiac Marker Revenue Market Share by Application (2020-2025)
 Table 67. Global Cardiac Marker Revenue Market Share by Application (2026-2031)
 Table 68. Global Cardiac Marker Price (USD/Dose) by Application (2020-2025)
 Table 69. Global Cardiac Marker Price (USD/Dose) by Application (2026-2031)
 Table 70. HyTest Company Information
 Table 71. HyTest Description and Business Overview
 Table 72. HyTest Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 73. HyTest Cardiac Marker Product
 Table 74. HyTest Recent Developments/Updates
 Table 75. Abbott Company Information
 Table 76. Abbott Description and Business Overview
 Table 77. Abbott Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 78. Abbott Cardiac Marker Product
 Table 79. Abbott Recent Developments/Updates
 Table 80. Roche Diagnostics Company Information
 Table 81. Roche Diagnostics Description and Business Overview
 Table 82. Roche Diagnostics Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 83. Roche Diagnostics Cardiac Marker Product
 Table 84. Roche Diagnostics Recent Developments/Updates
 Table 85. BG Medicine Company Information
 Table 86. BG Medicine Description and Business Overview
 Table 87. BG Medicine Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 88. BG Medicine Cardiac Marker Product
 Table 89. BG Medicine Recent Developments/Updates
 Table 90. Biomerieux Company Information
 Table 91. Biomerieux Description and Business Overview
 Table 92. Biomerieux Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 93. Biomerieux Cardiac Marker Product
 Table 94. Biomerieux Recent Developments/Updates
 Table 95. Critical Diagnostics Company Information
 Table 96. Critical Diagnostics Description and Business Overview
 Table 97. Critical Diagnostics Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 98. Critical Diagnostics Cardiac Marker Product
 Table 99. Critical Diagnostics Recent Developments/Updates
 Table 100. DiaDexus Company Information
 Table 101. DiaDexus Description and Business Overview
 Table 102. DiaDexus Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 103. DiaDexus Cardiac Marker Product
 Table 104. DiaDexus Recent Developments/Updates
 Table 105. Response Biomedical Company Information
 Table 106. Response Biomedical Description and Business Overview
 Table 107. Response Biomedical Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 108. Response Biomedical Cardiac Marker Product
 Table 109. Response Biomedical Recent Developments/Updates
 Table 110. Siemens Healthcare Company Information
 Table 111. Siemens Healthcare Description and Business Overview
 Table 112. Siemens Healthcare Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 113. Siemens Healthcare Cardiac Marker Product
 Table 114. Siemens Healthcare Recent Developments/Updates
 Table 115. Singulex Company Information
 Table 116. Singulex Description and Business Overview
 Table 117. Singulex Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 118. Singulex Cardiac Marker Product
 Table 119. Singulex Recent Developments/Updates
 Table 120. Thermo Scientific Company Information
 Table 121. Thermo Scientific Description and Business Overview
 Table 122. Thermo Scientific Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 123. Thermo Scientific Cardiac Marker Product
 Table 124. Thermo Scientific Recent Developments/Updates
 Table 125. Trinity Biotech Company Information
 Table 126. Trinity Biotech Description and Business Overview
 Table 127. Trinity Biotech Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 128. Trinity Biotech Cardiac Marker Product
 Table 129. Trinity Biotech Recent Developments/Updates
 Table 130. Sunfory Company Information
 Table 131. Sunfory Description and Business Overview
 Table 132. Sunfory Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 133. Sunfory Cardiac Marker Product
 Table 134. Sunfory Recent Developments/Updates
 Table 135. Lee BioSolutions Company Information
 Table 136. Lee BioSolutions Description and Business Overview
 Table 137. Lee BioSolutions Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 138. Lee BioSolutions Cardiac Marker Product
 Table 139. Lee BioSolutions Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Cardiac Marker Distributors List
 Table 143. Cardiac Marker Customers List
 Table 144. Cardiac Marker Market Trends
 Table 145. Cardiac Marker Market Drivers
 Table 146. Cardiac Marker Market Challenges
 Table 147. Cardiac Marker Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Cardiac Marker
 Figure 2. Global Cardiac Marker Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cardiac Marker Market Share by Type: 2024 & 2031
 Figure 4. Creatine kinase (CK) MB Product Picture
 Figure 5. Troponin (cTnI and cTnT) Product Picture
 Figure 6. BNP & NT-proBNP Product Picture
 Figure 7. Myogloblin Product Picture
 Figure 8. Others (hs-CRP, D-Dimer, etc.) Product Picture
 Figure 9. Global Cardiac Marker Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Cardiac Marker Market Share by Application: 2024 & 2031
 Figure 11. Myocardial Infarction
 Figure 12. Congestive Heart Failure
 Figure 13. Acute Coronary Syndrome
 Figure 14. Atherosclerosis
 Figure 15. Others
 Figure 16. Global Cardiac Marker Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Cardiac Marker Market Size (2020-2031) & (US$ Million)
 Figure 18. Global Cardiac Marker Sales (2020-2031) & (K Doses)
 Figure 19. Global Cardiac Marker Average Price (USD/Dose) & (2020-2031)
 Figure 20. Cardiac Marker Report Years Considered
 Figure 21. Cardiac Marker Sales Share by Manufacturers in 2024
 Figure 22. Global Cardiac Marker Revenue Share by Manufacturers in 2024
 Figure 23. Global 5 and 10 Largest Cardiac Marker Players: Market Share by Revenue in Cardiac Marker in 2024
 Figure 24. Cardiac Marker Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 25. Global Cardiac Marker Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 26. North America Cardiac Marker Sales Market Share by Country (2020-2031)
 Figure 27. North America Cardiac Marker Revenue Market Share by Country (2020-2031)
 Figure 28. U.S. Cardiac Marker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Canada Cardiac Marker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Europe Cardiac Marker Sales Market Share by Country (2020-2031)
 Figure 31. Europe Cardiac Marker Revenue Market Share by Country (2020-2031)
 Figure 32. Germany Cardiac Marker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. France Cardiac Marker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. U.K. Cardiac Marker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Italy Cardiac Marker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Russia Cardiac Marker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Asia Pacific Cardiac Marker Sales Market Share by Region (2020-2031)
 Figure 38. Asia Pacific Cardiac Marker Revenue Market Share by Region (2020-2031)
 Figure 39. China Cardiac Marker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Japan Cardiac Marker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. South Korea Cardiac Marker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. India Cardiac Marker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Australia Cardiac Marker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Taiwan Cardiac Marker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Indonesia Cardiac Marker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Thailand Cardiac Marker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Malaysia Cardiac Marker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Philippines Cardiac Marker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Latin America Cardiac Marker Sales Market Share by Country (2020-2031)
 Figure 50. Latin America Cardiac Marker Revenue Market Share by Country (2020-2031)
 Figure 51. Mexico Cardiac Marker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Brazil Cardiac Marker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Argentina Cardiac Marker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Middle East and Africa Cardiac Marker Sales Market Share by Country (2020-2031)
 Figure 55. Middle East and Africa Cardiac Marker Revenue Market Share by Country (2020-2031)
 Figure 56. Turkey Cardiac Marker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Saudi Arabia Cardiac Marker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. U.A.E Cardiac Marker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Global Sales Market Share of Cardiac Marker by Type (2020-2031)
 Figure 60. Global Revenue Market Share of Cardiac Marker by Type (2020-2031)
 Figure 61. Global Cardiac Marker Price (USD/Dose) by Type (2020-2031)
 Figure 62. Global Sales Market Share of Cardiac Marker by Application (2020-2031)
 Figure 63. Global Revenue Market Share of Cardiac Marker by Application (2020-2031)
 Figure 64. Global Cardiac Marker Price (USD/Dose) by Application (2020-2031)
 Figure 65. Cardiac Marker Value Chain
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc